Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1963 1
1966 1
1970 1
1979 1
1981 3
1983 2
1985 3
1986 4
1987 3
1988 8
1989 2
1990 4
1991 4
1992 6
1993 1
1994 5
1995 4
1996 7
1997 1
1998 10
1999 7
2000 5
2001 5
2002 7
2003 3
2004 5
2005 5
2006 2
2007 3
2008 15
2009 10
2010 15
2011 13
2012 20
2013 14
2014 16
2015 18
2016 26
2017 35
2018 32
2019 15
2020 15
2021 30
2022 26
2023 21
2024 28
2025 29

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

454 results

Results by year

Filters applied: . Clear all
Page 1
Geranylgeraniol-induced Myogenic Differentiation of C2C12 Cells.
Matsubara T, Urata M, Nakajima T, Fukuzaki M, Masuda R, Yoshimoto Y, Addison WN, Nakatomi C, Morikawa K, Zhang M, Saeki K, Takahashi Y, Nakamichi A, Kokabu S. Matsubara T, et al. Among authors: masuda r. In Vivo. 2018 Nov-Dec;32(6):1427-1431. doi: 10.21873/invivo.11395. In Vivo. 2018. PMID: 30348697 Free PMC article.
Collagen-like antimicrobial peptides.
Masuda R, Kudo M, Dazai Y, Mima T, Koide T. Masuda R, et al. Biopolymers. 2016 Nov 4;106(4):453-9. doi: 10.1002/bip.22791. Biopolymers. 2016. PMID: 27271210
Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial.
Misawa S, Kuwabara S, Sato Y, Yamaguchi N, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kanouchi T, Kohara N, Kawamoto M, Ishii J, Kuwahara M, Suzuki H, Hirata K, Kokubun N, Masuda R, Kaneko J, Yabe I, Sasaki H, Kaida KI, Takazaki H, Suzuki N, Suzuki S, Nodera H, Matsui N, Tsuji S, Koike H, Yamasaki R, Kusunoki S; Japanese Eculizumab Trial for GBS (JET-GBS) Study Group. Misawa S, et al. Among authors: masuda r. Lancet Neurol. 2018 Jun;17(6):519-529. doi: 10.1016/S1474-4422(18)30114-5. Epub 2018 Apr 21. Lancet Neurol. 2018. PMID: 29685815 Clinical Trial.
Collagen-like cell-penetrating peptides.
Yamazaki CM, Nakase I, Endo H, Kishimoto S, Mashiyama Y, Masuda R, Futaki S, Koide T. Yamazaki CM, et al. Among authors: masuda r. Angew Chem Int Ed Engl. 2013 May 17;52(21):5497-500. doi: 10.1002/anie.201301266. Epub 2013 Apr 16. Angew Chem Int Ed Engl. 2013. PMID: 23592529 No abstract available.
Isolable small-molecule cysteine sulfenic acid.
Sano T, Masuda R, Sase S, Goto K. Sano T, et al. Among authors: masuda r. Chem Commun (Camb). 2021 Mar 9;57(20):2479-2482. doi: 10.1039/d0cc08422k. Chem Commun (Camb). 2021. PMID: 33599629
Pharmacotherapy for Neuropathic Pain in Japan.
Masuda R, Ajimi J, Murata T. Masuda R, et al. J Nippon Med Sch. 2017;84(6):258-267. doi: 10.1272/jnms.84.258. J Nippon Med Sch. 2017. PMID: 29279555 Free article. Review.
454 results